A NEW drug designed to treat a form of breast cancer has been hailed as “groundbreaking” by top scientists – raising hopes of finding a cure. AstraZeneca said the trial of the medicine …
David Fredrickson, head of oncology at AstraZeneca, said that those who worked for the pharmaceutical giant shed tears of surprise when the data was revealed.
He said: “It’s remarkable to hear the oncology community, as they take the data in, say: ‘Is it possible that we could be offering a cure for some women with advanced disease?’”"These unprecedented data represent a potential paradigm shift in the treatment of HER2-positive metastatic breast cancer, and illustrate the potential for Enhertu to transform more patient lives in earlier treatment settings.
He said the the "high and consistent benefit" seen across key groups is "remarkable and supports the potential of Enhertu to become the new standard of care for those who have previously been treated for HER2-positive metastatic breast cancer". Enhertu has already been approved by the UK’s medicines regulator, the MHRA, and 34 other markets for women who have exhausted other treatments, such as chemotherapy.
The official price for a course of Enhertu is about £118,000, but AstraZeneca lets the NHS have it at a confidential discount.AstraZeneca have hailed the study as groundbreakingKerry Katona goes under the knife on TV as she has breast reduction complaining 'I'm really suffering'
Belgique Dernières Nouvelles, Belgique Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Rugby legend in race against time to get MND wonder drug to see kids grow upEx Leeds Rhinos star Rob Burrow hopes a groundbreaking treatment could buy him enough time for a cure to be found for Motor Neuron Disease which has put him in a wheelchair
Lire la suite »
Pfizer recall anti-smoking drug Chantix for high levels nitrosaminePfizer has voluntarily recalled its drug Chantix - which is used to help people stop smoking - for containing high levels of cancer-causing agents called nitrosamines.
Lire la suite »
New drug could slow tumour regrowth in inoperable bowel cancerAdavosertib found to delay tumour growth in some patients in clinical trial, with few side effects
Lire la suite »
Town to hold memorial service for victims of coronavirusThe organisers of the service in Bridgnorth said they hoped it would bring people closure.
Lire la suite »
Afghan evacuees in UK face homelessness and destitution, MPs sayConcerns raised over confusion between Home Office and councils over who will house arrivals
Lire la suite »
Maura Higgins opens up about a stranger grabbing her wristWe hope Maura's doing okay after this scary experience
Lire la suite »